ImmunityBio (IBRX) Equity Ratio (2014 - 2026)

ImmunityBio (IBRX) reported Equity Ratio of 1.34 for Q1 2026, up 30.86% year-over-year from 1.03 in Q1 2025, and down 34.79% quarter-over-quarter from 1.0 in Q4 2025.

ImmunityBio (IBRX) Equity Ratio (2014 - 2026) Analysis & Trends

ImmunityBio (IBRX) has 13 years of Equity Ratio data on file, last reported at 1.34 in Q1 2026.

  • Equity Ratio for Q1 2026 came in at 1.34, up 30.86% year-over-year; the trailing twelve-month figure through Mar 2026 was 1.34 (up 30.86% YoY), and the FY2025 annual result was 1.0, up 21.77% from the prior year.
  • Equity Ratio eased to 1.34 in Q1 2026 per IBRX's latest filing, from 1.0 in the prior quarter.
  • Over five years, Equity Ratio peaked at 0.87 in Q1 2022 and troughed at 2.22 in Q2 2023.
  • A 5-year average of 1.4 and a median of 1.33 in 2022 frame the typical range for Equity Ratio.
  • The sharpest annual moves came in 2022 and 2025: Equity Ratio slumped 138.65% in 2022, then surged 50.59% in 2025.
  • A 5-year view of Equity Ratio shows it stood at 1.24 in 2022, then grew by 6.43% to 1.16 in 2023, then slipped by 9.74% to 1.27 in 2024, then rose by 21.77% to 1.0 in 2025, then sank by 34.79% to 1.34 in 2026.
  • Business Quant data shows IBRX's Equity Ratio at 1.34 in Q1 2026, 1.0 in Q4 2025, and 1.01 in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Equity Ratio (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - 191.07
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - 0.98
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - 0.04
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn 0.58
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - 0.42
7 Psyence Biomedical 212.16 Bn 212.16 Bn - -
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn 0.73
9 Abivax 91.96 Bn 91.96 Bn - 0.79
10 ImmunityBio 7.55 Bn 7.17 Bn 43.97 Mn -1.34

Historic Data

Download Data
DateValue
Mar 31, 2026 -1.34
Dec 31, 2025 -1.00
Sep 30, 2025 -1.01
Jun 30, 2025 -1.42
Mar 31, 2025 -1.94
Dec 31, 2024 -1.27
Sep 30, 2024 -2.04
Jun 30, 2024 -1.57
Mar 31, 2024 -1.72
Dec 31, 2023 -1.16
Sep 30, 2023 -0.95
Jun 30, 2023 -2.22
Mar 31, 2023 -1.55
Dec 31, 2022 -1.24
Sep 30, 2022 -1.22
Jun 30, 2022 -1.33
Mar 31, 2022 -0.87
Dec 31, 2021 -0.52
Sep 30, 2021 -0.89
Jun 30, 2021 -0.64